As the liver is a primary target organ for GH and IGF-1, patients with GHD are at an increased risk of developing MASLD; both GHD and MASLD are recognized as major complications in adults with GHD (8). Here, GH1 is linked to metabolic dysfunction-associated steatotic liver disease.